IRIS Accounts Production v26.1.0.640 08681398 director 1.1.25 31.12.25 31.12.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086813982024-12-31086813982025-12-31086813982025-01-012025-12-31086813982023-12-31086813982024-01-012024-12-31086813982024-12-3108681398ns15:EnglandWales2025-01-012025-12-3108681398ns14:PoundSterling2025-01-012025-12-3108681398ns10:Director12025-01-012025-12-3108681398ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3108681398ns10:SmallEntities2025-01-012025-12-3108681398ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3108681398ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3108681398ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3108681398ns10:FullAccounts2025-01-012025-12-3108681398ns10:RegisteredOffice2025-01-012025-12-3108681398ns5:CurrentFinancialInstruments2025-12-3108681398ns5:CurrentFinancialInstruments2024-12-3108681398ns5:ShareCapital2025-12-3108681398ns5:ShareCapital2024-12-3108681398ns5:RetainedEarningsAccumulatedLosses2025-12-3108681398ns5:RetainedEarningsAccumulatedLosses2024-12-3108681398ns5:PlantMachinery2025-01-012025-12-3108681398ns5:FurnitureFittings2025-01-012025-12-3108681398ns5:ComputerEquipment2025-01-012025-12-3108681398ns5:PlantMachinery2024-12-3108681398ns5:FurnitureFittings2024-12-3108681398ns5:ComputerEquipment2024-12-3108681398ns5:PlantMachinery2025-12-3108681398ns5:FurnitureFittings2025-12-3108681398ns5:ComputerEquipment2025-12-3108681398ns5:PlantMachinery2024-12-3108681398ns5:FurnitureFittings2024-12-3108681398ns5:ComputerEquipment2024-12-3108681398ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3108681398ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31
REGISTERED NUMBER: 08681398 (England and Wales)








REPORT OF THE DIRECTOR AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

PROSUM MEDICAL LTD

PROSUM MEDICAL LTD (REGISTERED NUMBER: 08681398)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2025




Page

Company Information 1

Report of the Director 2

Balance Sheet 3 to 4

Notes to the Financial Statements 5 to 6


PROSUM MEDICAL LTD

COMPANY INFORMATION
for the Year Ended 31 December 2025







DIRECTOR: Mr Y Sun





REGISTERED OFFICE: Unit 14
Cowley Mill Road
Uxbridge
Greater London
UB8 2DB





REGISTERED NUMBER: 08681398 (England and Wales)






PROSUM MEDICAL LTD (REGISTERED NUMBER: 08681398)

REPORT OF THE DIRECTOR
for the Year Ended 31 December 2025

The director presents his report with the financial statements of the company for the year ended 31 December 2025.

DIRECTOR
Mr Y Sun held office during the whole of the period from 1 January 2025 to the date of this report.

His beneficial interest in the shares of the company, according to the register of directors' interests, was as follows:

31.12.25 1.1.25
Ordinary shares of £1 each 100,000 100,000

He did not hold any non-beneficial interests in the shares of the company.

GOING CONCERN
The Company director considers the Company a going concern on the basis that by the date of this report they have repaid the loan and he will continue to support the company personally.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Mr Y Sun - Director


28 August 2026

PROSUM MEDICAL LTD (REGISTERED NUMBER: 08681398)

BALANCE SHEET
31 December 2025

31.12.25 31.12.24
Notes £    £   
FIXED ASSETS
Property, plant and equipment 4 9,454 5,338

CURRENT ASSETS
Debtors 5 2,398,278 1,960,421
Cash at bank and in hand 582,184 916,080
2,980,462 2,876,501
CREDITORS
Amounts falling due within one year 6 (2,333,971 ) (2,377,516 )
NET CURRENT ASSETS 646,491 498,985
TOTAL ASSETS LESS CURRENT
LIABILITIES

655,945

504,323

PROVISIONS FOR LIABILITIES (2,364 ) (1,335 )
NET ASSETS 653,581 502,988

CAPITAL AND RESERVES
Called up share capital 100,000 100,000
Retained earnings 553,581 402,988
SHAREHOLDERS' FUNDS 653,581 502,988

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PROSUM MEDICAL LTD (REGISTERED NUMBER: 08681398)

BALANCE SHEET - continued
31 December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 August 2026 and were signed by:





Mr Y Sun - Director


PROSUM MEDICAL LTD (REGISTERED NUMBER: 08681398)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

Prosum Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

PROSUM MEDICAL LTD (REGISTERED NUMBER: 08681398)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 5 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 January 2025 320 8,944 6,935 16,199
Additions - 3,068 4,525 7,593
At 31 December 2025 320 12,012 11,460 23,792
DEPRECIATION
At 1 January 2025 219 5,786 4,856 10,861
Charge for year 25 1,556 1,896 3,477
At 31 December 2025 244 7,342 6,752 14,338
NET BOOK VALUE
At 31 December 2025 76 4,670 4,708 9,454
At 31 December 2024 101 3,158 2,079 5,338

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Trade debtors 1,951,570 1,810,700
Other debtors 446,708 149,721
2,398,278 1,960,421

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Bank loans and overdrafts 26,091 5,977
Trade creditors 2,174,075 2,298,510
Taxation and social security 56,150 31,525
Other creditors 77,655 41,504
2,333,971 2,377,516

7. ULTIMATE CONTROLLING PARTY

The controlling party is Mr Y Sun.